NVCR Archives - Spark Newswire

5 minute read

Novocure Announces Presentations On Tumor Treating Fields Therapy, Including New Clinical Data And Real-World Evidence, At 2023 Society For Neuro-Oncology Annual Meeting

November 10, 9:04 AM

Novocure (NASDAQ:NVCR) today announced that research on Tumor Treating Fields (TTFields) therapy, including new data from the phase 2 2-THE-TOP trial and real-world evidence from patients diagnosed with glioblastoma

NVCR

17 minute read

Earnings

Earnings Scheduled For October 26, 2023

By Benzinga Insights

October 26, 7:20 AM

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion.

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

October 5, 1:35 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

ALNY

23 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

October 5, 1:22 PM

On Thursday, 369 companies hit new 52-week lows.

22 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

October 4, 12:01 PM

On Wednesday, 311 stocks hit new 52-week lows.

AADI

37 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

October 3, 2:37 PM

On Tuesday, 647 companies set new 52-week lows.

AADI

8 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

September 29, 2:09 PM

Friday's session saw 112 companies set new 52-week lows.

AADI

24 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

September 28, 2:32 PM

During Thursday's session, 406 companies made new 52-week lows.

AAP

28 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

September 21, 12:08 PM

During the session on Thursday, 461 stocks hit new 52-week lows.

$TKO

3 minute read

Novocure Highlights Use Of Tumor Treating Fields Therapy In Treatment Of Non-Small Cell Lung Cancer At 2023 World Conference On Lung Cancer

By Benzinga Newsdesk

September 8, 4:03 PM

Presentations include new post-hoc analysis of data from phase 3 LUNAR trial in metastatic non-small cell lung cancerNovocure (NASDAQ:NVCR) today announced its participation in the upcoming International Association for

NVCR

Feed Symbols: NVCR